Zuellig Pharma China
Zuellig Pharma China distributes pharmaceutical, consumer healthcare, and clinical trial supplies across China as part of Asia-Pacific's largest integrated healthcare solutions company, serving hospitals, clinics, and pharmacies via an eZRx+ B2B platform and 71 regional warehouses.
- Company typePrivate
- Founded1922
- HeadquartersWanchai, China
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What Zuellig Pharma China does
Zuellig Pharma China is the China operations of Zuellig Pharma, Asia's largest integrated pharmaceutical distribution and healthcare solutions company. The business distributes pharmaceutical, consumer healthcare, vaccine, medical device, animal health, and specialty care products to hospitals, clinics, pharmacies, and other healthcare channels, complemented by market access and regulatory affairs services for pharmaceutical manufacturers and clinical trial logistics for global CROs. Within China, operations are anchored by a regional headquarters in Beijing and a clinical depot in the Shunyi District of Shanghai, feeding into the parent's 18-market, 71-warehouse Asia-Pacific footprint that reaches 200,000+ customers including 22,000 hospitals, 55,000 clinics, and 90,000 pharmacies.
The technology stack centers on the eZRx+ B2B eCommerce platform for ordering and fulfillment, complemented by eZTracker (blockchain supply chain traceability), eZTender (tender and contract management), eZCooler (passive 2-8°C cold chain), and PatientCare+ (rare disease, immuno-oncology, and chronic condition patient support). Clinical trial supply is operated through the Clinical Reach network (26+ depots across 60+ markets) and recently automated via Hai Robotics' HaiPick System 1 at the South Korea CTS Innovation Center, which supports ambient, cold, frozen, deep frozen, and cryogenic temperature zones. GxP, GDP, GMP, and ISO 9001 certifications underpin a quality framework recognized through EcoVadis Platinum and CDP A-List 2024 awards.
Revenue is generated through three streams: (1) contract-based pharmaceutical distribution services generating transaction fees on storage, logistics, and last-mile delivery; (2) brand commercialization and acquisition of established consumer healthcare brands such as Zam-Buk, Vapex, Propan, and now Cialis rights, monetized via OTC sales and royalties; and (3) market access solutions including regulatory support, market entry, and commercial execution for pharma manufacturers, billed as professional services. Pricing is quote-based and negotiated under multi-year contracts. The GTM motion combines a 2,500+ rep direct enterprise field sales force with the eZRx+ digital channel. The Zuellig family retains majority control, with a minority stake held by Singapore sovereign wealth fund Temasek Holdings (since 2007).
Zuellig Pharma China firmographics
Firmographics- Name
- Zuellig Pharma China
- Legal name
- Zuellig Pharma Pte Ltd
- Website
- https://zuelligpharma.com
- Company type
- Private
- Founded year
- 1922
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Zuellig Pharma China distributes pharmaceutical, consumer healthcare, and clinical trial supplies across China as part of Asia-Pacific's largest integrated healthcare solutions company, serving hospitals, clinics, and pharmacies via an eZRx+ B2B platform and 71 regional warehouses.
- Ownership category
- akta.pro rank
Zuellig Pharma China industry classification
Industry- Product category
- Pharmaceutical Distribution Services
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
- akta.pro secondary industries
- Vaccines & Cold-Chain Pharmaceutical Distributors (HLAIAJAG), Pharmaceutical & Life Sciences Cold Chain Storage (2–8°C / CRT) (TLALABAF), Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)
Keywords
Where Zuellig Pharma China is headquartered
LocationHeadquarters
- HQ city
- Wanchai
- HQ country
- China
- HQ region
- Asia
Offices19 records
Markets served
Zuellig Pharma China business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Infrastructure, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Distribution Services: Core distribution services for pharmaceutical products including storage, logistics, and last-mile delivery to healthcare facilities
- Brand Acquisitions: Acquisition and distribution of established consumer healthcare brands such as Zam-Buk, Vapex, and Propan
- Market Access Solutions: Helping pharmaceutical manufacturers access Asian markets through regulatory support, market entry, and commercial execution
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Contract-based pharmaceutical distribution pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels1 record
Zuellig Pharma China product offering
Product offeringCore offering
Zuellig Pharma China distributes pharmaceutical, medical device, consumer healthcare, vaccine, animal health, and specialty care products to hospitals, clinics, and pharmacies across Asia-Pacific. The company operates a network of 71 warehouses with multi-zone temperature-controlled storage, runs a direct sales force of 2,500+ representatives, and supports the full pharmaceutical value chain through its B2B eCommerce platform (eZRx+), clinical trial logistics services, and commercialization/market access solutions.
Differentiator
Problem solved
Functional benefit
Brands
- eZRx+: ASEAN's largest B2B healthcare eCommerce platform for ordering pharmaceutical products
- eZTracker
- eZTender
- eZCooler
- PatientCare+
- EZ Rx
- Clinical Reach
Products and services
- eZRx+ B2B eCommerce platform enabling healthcare providers to order pharmaceutical and healthcare products online with order visibility, analytics, and digital fulfillment integration.
- eZTracker
Quantifiable outcome
- 200,000+ healthcare facilities served across Asia-Pacific
- +2 more outcomes
Companies that use Zuellig Pharma China
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
Zuellig Pharma China technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Zuellig Pharma China partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered major, core and minor.
- Bayer Consumer Care AGmajorAcquisition of Zam-Buk and Vapex consumer healthcare brands from Bayer, expanding Zuellig's portfolio of over-the-counter products across Asia-Pacific markets
- Eli Lilly and CompanymajorStrategic partnership including acquisition of Cialis rights and distribution of Mounjaro (tirzepatide) in Asia-Pacific markets
- LundbeckcoreExpanded partnership for neuro-psychiatric health solutions distribution across Asia-Pacific markets
- OrganoncorePartnership for women's health solutions distribution in Myanmar, expanding women's health portfolio
- ADP Pharma CorporationminorAcquisition of Propan brand, expanding consumer healthcare product portfolio
- Hai RoboticscorePartnership for clinical trial logistics automation, implementing automated storage and retrieval systems for clinical trial supplies
Scale indicators12 records
Recent moves8 records
Expansion highlights6 records
Zuellig Pharma China competitors and assessment
Company assessmentRegional players
- Yusen Logistics: Japan-headquartered global logistics provider with significant healthcare and pharmaceutical logistics capabilities across Asia-Pacific. Comparable in temperature-controlled distribution infrastructure but as a logistics specialist rather than full-service pharmaceutical distributor.
Broad incumbents
- Walgreens Boots Alliance: Global pharmacy-led, health and wellbeing retail and wholesale company. Comparable in the integrated pharma distribution plus retail/wholesale pharmacy model, though predominantly US/Europe rather than Asia.
- Cardinal Health: US-based Fortune 500 pharmaceutical distributor and medical products company. Operates similar wholesale distribution and specialty services model as Zuellig but predominantly serves North American customers.
- McKesson Corporation: Largest pharmaceutical distributor globally, operating a multinational wholesale and specialty distribution platform. Comparable in core pharmaceutical distribution model but with global rather than Asia-focused footprint and broader product portfolio.
- AmerisourceBergen (Cencora): Global pharmaceutical distribution and consulting services company formed from AmerisourceBergen. Closely aligned with Zuellig's distribution-plus-services model at much larger scale and global reach.
Direct peers
- Sinopharm Group: China's largest pharmaceutical distributor and state-owned enterprise, operating the dominant drug distribution network across mainland China. Direct competitor in the China market and comparable at scale in pharmaceutical wholesale and cold chain logistics.
- DKSH Holding: Swiss-headquartered market expansion services group specializing in pharmaceutical and consumer goods distribution across Asia-Pacific. Most direct comparable given overlapping Asia footprint, healthcare distribution focus, and similar agency/commercialization service model.
- Shanghai Pharmaceuticals Holding: Major state-owned pharmaceutical manufacturer and distributor in China with both manufacturing and distribution operations. Directly comparable in pharmaceutical wholesale distribution across Chinese and select APAC markets.
- China Resources Pharmaceutical Group: Hong Kong-listed pharmaceutical distributor and manufacturer under China Resources Holdings, with extensive distribution network in mainland China and select APAC markets. Comparable in scale, business model, and regional product mix.
Emerging players
- CEVA Logistics: Global third-party logistics provider (CMA CGM subsidiary) with growing healthcare and pharmaceutical logistics capabilities in Asia. Partial overlap with Zuellig's contract logistics and cold chain offerings, focused on transportation rather than full-service distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Zuellig Pharma China social profiles
Digital presenceZuellig Pharma China financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zuellig Pharma China leadership team
Management profileNumber of profiles
Profiles12 records
Zuellig Pharma China subsidiaries and ownership
Company hierarchySubsidiaries8 records
Zuellig Pharma China funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zuellig Pharma China M&A and investment
M&A and investmentM&A4 records
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zuellig Pharma China
What does Zuellig Pharma China do?
Zuellig Pharma China distributes pharmaceutical, medical device, consumer healthcare, vaccine, animal health, and specialty care products to hospitals, clinics, and pharmacies across Asia-Pacific. The company operates a network of 71 warehouses with multi-zone temperature-controlled storage, runs a direct sales force of 2,500+ representatives, and supports the full pharmaceutical value chain through its B2B eCommerce platform (eZRx+), clinical trial logistics services, and commercialization/market access solutions.
Is Zuellig Pharma China a public or private company?
Zuellig Pharma China is a private company. It is classified as family owned and is currently operating.
When was Zuellig Pharma China founded?
Zuellig Pharma China was founded in 1922. It employs 5,001 to 10,000 people.
Where is Zuellig Pharma China based?
Zuellig Pharma China is headquartered in Wanchai, China, in the Asia region.
How does Zuellig Pharma China make money?
Three revenue lines are on record. Pharmaceutical Distribution Services are the primary driver. The others are brand Acquisitions and market Access Solutions.
Who are Zuellig Pharma China's main competitors?
Yusen Logistics is listed as a regional player. Broad incumbents are Walgreens Boots Alliance, Cardinal Health, McKesson Corporation and AmerisourceBergen (Cencora). Direct peers are Sinopharm Group, DKSH Holding, Shanghai Pharmaceuticals Holding and China Resources Pharmaceutical Group. CEVA Logistics is listed as an emerging player.
Does Zuellig Pharma China have an API?
No public API is recorded for Zuellig Pharma China.
What industry is Zuellig Pharma China in?
Zuellig Pharma China's product category is Pharmaceutical Distribution Services. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of HLAIAJAG, Vaccines & Cold-Chain Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.